INTRODUCTION

Definition and Epidemiology
Graves' orbitopathy (GO) or thyroid eye disease (TED) is a disabling ocular presentation of Graves' disease (GD), causing cosmetic changes and functional alterations. TED will present in almost 50% of GD cases, whereas approximately 5% of patients will develop severe disease with dysthyroid compressive optic neuropathy (DON) [1] . Recent epidemiological studies show that GD has an incidence of 210 per million per year in Sweden, presenting more frequently in the fifth decade of life. It more frequently affects women than men, with a female to male ratio of 4:1. TED It is an autoimmune disorder with an incidence of 42 per million per year [2] . The orbit is affected due to expression of organ-specific autoantibodies against the thyroid stimulating receptor (TSH receptor) which presents both in thyroid and periocular tissues [3] . Moderate-to-severe and very severe GO will develop in 5-6% of GD cases, whereas mild GO resolves spontaneously in most cases [4, 5] .
Clinical presentation involves inflammation of the orbital and periocular tissues, edema of the extraocular muscles, and fat proliferation, which increase the orbital volume, resulting in exophthalmos and eyelid retraction. Restrictive ocular myopathy due to muscle enlargement and fibrosis result in diplopia. Eyelids, conjunctiva, and caruncle most frequently develop erythema and swelling due to inflammation [6] .
TED manifests initially with an active inflammatory stage followed by a burnt out fibrotic phase. Management of the active disease is based on euthyroidism, anti-inflammatory and immunosuppressive agents, or retrobulbar radiotherapy guided by the disease activity and severity scores [7] .
However, functional and esthetic recovery in the fibrotic stage may be incomplete, and residual tissue scarring combined with permanent periocular changes result in persistent exophthalmos, diplopia, and lid retraction, which require multiple rehabilitative surgical interventions [8, 9] .
Finally, the disease significantly diminishes the quality of life [10] .
Intervention
Orbital decompression is the indicated intervention to restore optic nerve function in cases with DON, to correct or prevent exposure keratopathy due to lagophthalmos, and to rehabilitate patients with disfiguring exophthalmos. Surgery is performed by removing orbital bone, fat, or both and has only been applied for cosmetic rehabilitation in the 1990s [11] [12] [13] . It aims for the removal of medial, lateral, and inferior bony walls; this expands the orbital space into the paranasal sinuses and therefore increases the total volume. The literature suggests that three-wall decompression is indicated in cases with high degrees of proptosis, whereas two-wall decompression is more appropriate for cases with less exophthalmos [14] [15] [16] [17] [18] . Removal of the deep lateral wall maximizes the decompressive effect [19] . The addition of fat removal increases the safety of the procedure and the magnitude of proptosis reduction [20, 21] . There is extensive literature describing the various techniques for orbital decompression but there is no consensus on the most efficient and safe intervention [8, 12, 13, 20, 22- The present study summarizes the current evidence-based data on the efficacy of surgical orbital decompression for TED and possible information on complications and quality of life.
METHODS
The foundation of this review is a previously conducted systematic review and meta-analysis for the Cochrane Collaboration [22] . We did not require the approval of our institutional review board as the analysis in this article evaluates previously conducted studies and does not involve any new studies of human or animal subjects performed by any of the authors. Reporting of the methodology and results of the systematic review was guided by the PRISMA guidelines [30] .
Inclusion Criteria
The review includes unrestricted randomized controlled trials (RCTs) resulting from a detailed search strategy. In addition, review or large case series non-randomized studies will be analyzed. March 2015, based on the strategy suggested by Glanville et al. [38] (see ''Appendix'').
Outcome Measures
The reference lists of the included trials were assessed with the Science Citation Index for possible publications that cited the included trials in this review. We contacted investigators and experts in the field for additional trials.
Data Collection and Analysis
Search results screened for appropriate studies.
We reviewed the full text of studies with relevance to the review and assessed for methodological quality those that met the selection criteria. Disagreements were resolved by discussion. We extracted data onto a standardized data extraction form, reconciled differences and resolved disagreements before contacting investigators for further information where data was unclear.
Risk of Bias Assessment
Included trials were assessed for risk of bias following Higgins et al.'s methodology [39] . Possible areas for risk of bias were selection process and sequence generation, incomplete outcome data, and selective outcome reporting, classifying each trial as low, unclear, or high risk of bias.
For measures of treatment effect we followed the methodology for Systematic Reviews of
Interventions suggested by Deeks et al. [40] . We used the odds ratio for the primary outcome measure (success or failure of treatment) as reported data was dichotomous. A possible unit of analysis issue is the inclusion of both eyes from participants with no provision for this in the analysis. When relevant data from the included studies was unclear or incomplete, we contacted the investigators for the missing information.
Variety of study designs and methodological differences would normally produce some degree of heterogeneity. Should more trials be included in future updates, we will assess statistical heterogeneity and consistency between using the I 2 statistic and funnel plot analysis for publication bias. The two included studies revealed substantial clinical heterogeneity and meta-analysis of the results was not appropriate; we therefore present a descriptive summary of results supplemented with clinically important data from excluded studies.
Compliance with Ethics
The analysis in this article is based on previously conducted studies and does not involve any new studies of human or animal subjects performed by any of the authors.
RESULTS
Results of Search Strategy
The updated electronic searches revealed 1195 titles, 160 more than the published Cochrane review [22] . After removing duplicated and irrelevant results, we scanned 1058 records and discarded 914 titles because they were outside the scope of our review. From the remaining 144 references, there were no additional RCTs identified from the ones that were included in our systematic review (Fig. 1 (Table 2 ).
In the second study, Wakelkamp et al. [42] compared the surgical bony wall removal via a coronal approach with the intravenous administration of methylprednisolone for DON (Table 3) . There was an improvement in visual acuity, total eye and clinical activity scores at 52 weeks post treatment). Success was reported in 56% of the steroid group and 17% of the surgical group in cases of DON (Table 4) .
Additional interventions were recorded in a mean follow-up of 64 months for the surgery group where five out of six participants needed immunosuppression and three out of six needed squint surgery, followed by eyelid surgery in five out of six. Similarly, within 78 months in the steroids group, four out of nine had a decompression, and later five out of nine participants needed squint surgery, followed by eyelid surgery in four out of nine.
From the total number of 15 randomized participants, only two did not require rehabilitative surgery and they were both in the steroids group. Five participants in the same group did not undergo surgical decompression (Table 5 ). Treatment side effects were more frequent in the steroids group and included weight gain and a cushingoid appearance in 12 out of 15 patients, hypertension and reversible hyperglycemia in one case, and visual deterioration in one eye due to retinal vein occlusion. Side effects of surgery were transient infraorbital hypoesthesia in four out of 14 participants, and strabismus in one participant. Wakelkamp et al. [42] randomized patients following pretreatment stratification using Table 6 ).
Risk of Bias in Included Studies
The three-wall procedures were associated with more complications than two-wall decompressions and specifically in the coronal approach; complications were more frequent and severe. Adverse events included maxillary sinus obstruction, hypoglobus, and persistent eyelid swelling with scar dissatisfaction in the swinging eyelid three-wall procedures.
Temporal bossing, paralysis of frontalis muscle, and cerebrospinal fluid (CSF) leak occurred after coronal approach, whereas the last of these also occurred with the endoscopic approach. Olivary first introduced removal of periocular fat for orbital decompression in 1991. The average amount of fat removed was 6.0 cc and resulted in a 5.9-mm reduction of proptosis which is comparable to the published results for removal of bony wall [75] [76] [77] . Other studies report contradictory results with more fat excision required per millimeter of proptosis reduction (mean 7.3 ml of fat for a 4.7-mm reduction) with the technique, producing significantly less reduction of exophthalmos [78] [79] [80] [81] . Intraconal fat removal, alone or in combination with other techniques, may effectively alleviate optic nerve compression.
The literature reports suggest it is comparable to bony decompression for the management of DON in selected cases [27, 72, 81, 82] .
DISCUSSION
We did not find RCTs to support robust evidence for recommending a specific method for orbital decompression, as a result of the significant diversity of design, methodology, and outcome measures. [42] have documented the superiority of intravenous steroids for the management of DON but this trial was small and the observed difference was not statistically significant.
The body of evidence from the included studies does not allow for a documented conclusion regarding the objectives of this review. The study by Pliego-Maldonado et al.
[41] is lacking information on allocation of treatment and masking and has a comparatively short follow-up period of 4 months. In contrast, Wakelkamp et al. [42] offer high methodological quality, but include a small number of patients (six and nine patients in each treatment arm) so that the observed difference between groups can be attributed to chance. The limited number of studies and the significant methodological diversity do not allow for a meta-analysis of the results. The available evidence relates to the review question but it is insufficient to address all the review objectives.
Potential risk of other sources of bias was unclear in both studies. This was due to the small number of patients in the Wakelkamp et al. study [42] and poor methodological quality and short follow-up in the Pliego-Maldonado et al. study [41] . Bias may distort systematic reviews and meta-analyses and encourages the use of questionable treatments [83] . This is not an issue for this review because of lack of adequate evidence to formulate recommendations for practice.
There are an abundance of published data on surgical orbital decompression for TED, mainly retrospective, cohort, and case series studies. These studies do not contribute to the development of documented guidelines for the efficacy and safety of a specific procedure except in cases of DON because they relate to different indications for decompression, different stages of TED with different outcome measures.
A descriptive summary of the available uncontrolled studies may suggest that three-wall decompression is the most effective procedure in reducing exophthalmos but is associated with a higher rate of complications, mainly hypoglobus and induced diplopia [28, 44, 47, 84] . Surgical preference is shifting towards safer techniques with similar effect but fewer complications like the balance two-wall decompression or removal of the deep lateral wall [19, 25, 28, 60 ]. Removal of the medial wall is indicated for relief of optic nerve compression in cases of DON and is better performed via transcaruncular or endoscopic approach [72, 73, 85] . Removal of periocular fat may alleviate the intraorbital pressure and is even effective in cases of DON [27, 72, 79, 80, 82] . In clinical practice, the techniques for removal of medial and lateral wall are often used in combination with or without endoscopic assistance and their result is augmented by additional fat removal [21, 72, [86] [87] [88] . 
Recent improvements in
